Tuesday, December 20, 2016

UPDATE 1-U.S. extends review of Roche MS drug Ocrevus by three months

ZURICH, Dec 20 (Reuters) - The U.S. Food and Drug

Administration (FDA) has extended its review of Roche's

multiple sclerosis (MS) drug Ocrevus by three months to March

28, the Swiss drugmaker said...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)